Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Income Statement [Abstract]
Net sales	$ 60,821	$ 40,633	$ 165,508	$ 119,157
Cost of products sold	50,491	35,011	140,281	104,264
Gross profit	10,330	5,622	25,227	14,893
Operating expenses	8,026	6,490	22,564	19,742
Operating profit (loss)	2,304	(868)	2,663	(4,849)
Pension (expense) income	(18)	88	(53)	266
Other income, net	210	51	756	149
Interest expense	(436)	(158)	(1,190)	(396)
Profit (loss) before income taxes	2,060	(887)	2,176	(4,830)
Income tax expense	962	399	1,911	845
Net earnings (loss)	1,098	(1,286)	265	(5,675)
Less: Net earnings attributable to the non-controlling interest	375	33	532	89
Net earnings (loss) attributable to Kewaunee Scientific Corporation	$ 723	$ (1,319)	$ (267)	$ (5,764)
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders
Basic (in dollars per share)	$ 0.26	$ (0.47)	$ (0.09)	$ (2.07)
Diluted (in dollars per share)	$ 0.25	$ (0.47)	$ (0.09)	$ (2.07)
Weighted average number of common shares outstanding
Basic (in shares)	2,830	2,790	2,822	2,785
Diluted (in shares)	2,911	2,790	2,822	2,785

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227